The autoimmune bullous disease

Journal of the Royal College of Physicians of London

Volumn 31, Issue 4, 1997, Pages 364-368

  Wakelin, S H ^a   Black, M M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; SULFONAMIDE;

AUTOIMMUNITY; BULLOUS SKIN DISEASE; SHORT SURVEY;

AUTOIMMUNE DISEASES; DERMATITIS HERPETIFORMIS; DIAGNOSIS, DIFFERENTIAL; EPIDERMOLYSIS BULLOSA ACQUISITA; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS; PEMPHIGUS; PROGNOSIS; SKIN DISEASES, VESICULOBULLOUS;

EID: 0030877926     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Joyce Rico M. Autoimmune blistering diseases: characterization of target antigens. Adv Dermatol 1993;8:3-29.
2. Jordan RE, Kawana S, Fritz KA. Immunopathological mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol 1985;85(Suppl):72-8.
3. Wakelin SH, Wojnarowska F. Immunobullous diseases. In: Bos JD (ed). The skin immune system, 2nd edn. New York: Boca Raton, 1997:445-60.
4. Bernard P, Vaillant L, Labeille B, Bedane C, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 1995;131:48-52.
5. Amagi M. Autoantibodies against cell adhesion molecules in pemphigus. J Dermatol 1994;21:833-7.
6. Shimizu H, Masunaga T, Ishiko A, Kikuchi A, et al. Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to extracellular regions of desmosomes in different layers of human epidermis. J Invest Dermatol 1995;105:153-9.
7. Liu Z, Diaz LA, Giudice GA. Autoimmune response against the bullous pemphigoid 180 autoantigen. Dermatology 1994;189:34-7.
8. Soh H, Hosokawa H, Asada Y. IgE and its related phenomena in bullous pemphigoid Br J Dermatol 1993;128:371-7.
9. Modre B, Allen J, Wojnarowska F. Is class switching a mechanism of disease remission in bullous pemphigoid? Br J Dermatol 1995;132:654 (abstract).
10. Elder MJ, Lightman S. The immunological features and pathophysiology of ocular cicatricial pemphigoid. Eye 1994;8:196-9.
11. Black MM. New observations on pemphigoid 'herpes' gestationis. Dermatology 1994;189(Suppl):50-1.
12. Collier PM, Wojnarowska F. Linear IgA disease and chronic bullous disease of childhood. Eur J Dermatol 1993;3: 623-34.
13. Reunala T. Incidence of familial dermatitis herpetiformis. Br J Dermatol 1996; 134:394-8.
14. Lewis HM, Reunala T, Garioch JJ, Leonard JN, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996;135:363-7.
15. Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Dermatol Clin 1993;11:535-47.
16. Kirtschig G, Wojnarowska F. Autoimmune blistering diseases: an update of diagnostic methods and investigations. Clin Exp Dermatol 1994;19:97-112.
17. Gammon WR, Fine J-D, Forbes M, Briggaman RA. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992;27:79-87.
18. Huigol SC, Black MM. Management of the immunobullous disorders. I. Pemphigoid. Clin Exp Dermatol 1995;20: 189-201.
19. Huigol SC, Black MM. Management of the immunobullous diseases. II. Pemphigus. Clin Exp Dermatol 1995;20: 283-93.